NeuroBo Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
NeuroBo Pharmaceuticals, Inc.‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 2.29% of the total amount of its stocks outstanding. This makes up a total of 59.05K shares of NeuroBo Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -95.76% or -1.33M shares fewer. As for the holding position changes, 40% (2) of current hedge fund investors increased the number of shares held, and 60% (3) closed the holdings completely.
Hedge funds holding NeuroBo Pharmaceuticals (Q3 2018 – Q1 2023)
| Q3 2018 | 0 |
|---|---|
| Q4 2018 | 0 |
| Q1 2019 | 0 |
| Q3 2019 | 0 |
| Q4 2019 | 5 |
| Q1 2020 | 11 |
| Q2 2020 | 25 |
| Q3 2020 | 25 |
| Q4 2020 | 29 |
| Q1 2021 | 30 |
| Q2 2021 | 24 |
| Q3 2021 | 14 |
| Q4 2021 | 14 |
| Q1 2022 | 14 |
| Q2 2022 | 15 |
| Q3 2022 | 5 |
| Q4 2022 | 17 |
| Q1 2023 | 5 |
Hedge funds changes in NeuroBo Pharmaceuticals positions (Q3 2018 – Q1 2023)
| Q3 2018 | 0 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2018 | 0 | 0 | 0 | 0 | 0 |
| Q1 2019 | 0 | 0 | 0 | 0 | 0 |
| Q3 2019 | 0 | 0 | 0 | 0 | 0 |
| Q4 2019 | 5 | 0 | 0 | 0 | 0 |
| Q1 2020 | 7 | 1 | 2 | 1 | 0 |
| Q2 2020 | 17 | 5 | 2 | 3 | -2 |
| Q3 2020 | 2 | 7 | 10 | 2 | 4 |
| Q4 2020 | 4 | 12 | 7 | 0 | 6 |
| Q1 2021 | 6 | 13 | 6 | 5 | 0 |
| Q2 2021 | 10 | 4 | 9 | 16 | -15 |
| Q3 2021 | 1 | 4 | 5 | 11 | -7 |
| Q4 2021 | 5 | 1 | 4 | 5 | -1 |
| Q1 2022 | 4 | 2 | 5 | 4 | -1 |
| Q2 2022 | 3 | 2 | 3 | 2 | 5 |
| Q3 2022 | 5 | 0 | 0 | 15 | -15 |
| Q4 2022 | 14 | 2 | 1 | 2 | -2 |
| Q1 2023 | 0 | 2 | 0 | 3 | 0 |
Hedge funds changes in NeuroBo Pharmaceuticals stock options (Q3 2018 – Q1 2023)
| Q3 2018 | 0 | 2,000 |
|---|---|---|
| Q4 2018 | 0 | 1,000 |
| Q1 2019 | 0 | 0 |
| Q3 2019 | 0 | 1,000 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 928,000 | 144,000 |
| Q2 2021 | 549,000 | 169,000 |
| Q3 2021 | 456,000 | 354,000 |
| Q4 2021 | 201,000 | 133,000 |
| Q1 2022 | 14,000 | 0 |
| Q2 2022 | 6,000 | 0 |
| Q3 2022 | 137,000 | 0 |
| Q4 2022 | 0 | 72 |
| Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| VANGUARD GROUP INC | 156K | 11.39K | 0.000% |
| GROUP ONE TRADING, L.P. | 137K | 10K | 0.000% |
| UBS GROUP AG | 52K | 3.76K | 0.000% |
| BLACKROCK INC. Larry Fink | 9K | 686 | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 2K | 178 | 0.000% |
| BNP PARIBAS ARBITRAGE, SNC | 520 | 38 | 0.000% |
| NORTHERN TRUST CORP | 0 | 0 | 0.000% |
| BLACKROCK INC. Larry Fink | 0 | 0 | 0.000% |
| TWO SIGMA SECURITIES, LLC | 0 | 0 | 0.000% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0 | 0 | 0.000% |
| SABBY MANAGEMENT, LLC | 0 | 0 | 0.000% |
| VANGUARD GROUP INC | 0 | 0 | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0 | 0 | 0.000% |
| UBS GROUP AG | 0 | 0 | 0.000% |
| CAPTRUST FINANCIAL ADVISORS | 0 | 0 | 0.000% |
| MOUNT YALE INVESTMENT ADVISORS, LLC | 0 | 0 | 0.000% |
| STATE STREET CORP | 0 | 0 | 0.000% |
| MURCHINSON LTD. | 0 | 0 | 0.000% |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 0 | 0 | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 0 | 0 | 0.000% |
| MILLENNIUM MANAGEMENT LLC Israel Englander | 0 | 0 | 0.000% |